Published in Circulation on January 01, 1990
Limited forward trafficking of connexin 43 reduces cell-cell coupling in stressed human and mouse myocardium. J Clin Invest (2009) 1.98
Relation between left ventricular function and oxidative stress in patients undergoing bypass surgery. Heart (1998) 1.56
Real-time monitoring of endogenous lipid peroxidation by exhaled ethylene in patients undergoing cardiac surgery. Am J Physiol Lung Cell Mol Physiol (2014) 1.43
Post-operative atrial fibrillation: a maze of mechanisms. Europace (2011) 1.12
Determination of thiols and disulfides via HPLC quantification of 5-thio-2-nitrobenzoic acid. J Pharm Biomed Anal (2008) 1.02
Characterization of a novel dithiocarbamate glutathione reductase inhibitor and its use as a tool to modulate intracellular glutathione. J Biol Chem (2008) 1.02
N-acetylcysteine and allopurinol confer synergy in attenuating myocardial ischemia injury via restoring HIF-1α/HO-1 signaling in diabetic rats. PLoS One (2013) 1.00
Cardioprotective activity of silymarin in ischemia-reperfusion-induced myocardial infarction in albino rats. Exp Clin Cardiol (2007) 0.97
The delivery of superoxide dismutase encapsulated in polyketal microparticles to rat myocardium and protection from myocardial ischemia-reperfusion injury. Biomaterials (2009) 0.95
Basic mechanisms involved in the protection of the ischaemic myocardium. The role of calcium antagonists. Drugs (1991) 0.90
Pathobiology and Clinical Impact of Reperfusion Injury. J Thromb Thrombolysis (1997) 0.89
Hyperoxia during one lung ventilation: inflammatory and oxidative responses. Pediatr Pulmonol (2012) 0.87
Oxidative stress: Predictive marker for coronary artery disease. Exp Clin Cardiol (2013) 0.86
Reduction of oxidative stress does not affect recovery of myocardial function: warm continuous versus cold intermittent blood cardioplegia. Heart (1997) 0.86
Left ventricular dysfunction due to stunning and hibernation in patients. Cardiovasc Drugs Ther (1994) 0.85
Delivery of Nox2-NADPH oxidase siRNA with polyketal nanoparticles for improving cardiac function following myocardial infarction. Biomaterials (2013) 0.84
Cardioprotective effects of glycyrrhizic acid against isoproterenol-induced myocardial ischemia in rats. Int J Mol Sci (2011) 0.83
Oxidant-antioxidant balance during on-pump coronary artery bypass grafting. ScientificWorldJournal (2014) 0.83
Protective effects of low-frequency magnetic fields on cardiomyocytes from ischemia reperfusion injury via ROS and NO/ONOO-. Oxid Med Cell Longev (2013) 0.83
Oxidative stress and mitochondrial functions in the intestinal Caco-2/15 cell line. PLoS One (2010) 0.82
Evidence that continuous normothermic blood cardioplegia offers better myocardial protection than intermittent hypothermic cardioplegia. Br Heart J (1995) 0.81
AMPK Facilitates Nuclear Accumulation of Nrf2 by Phosphorylating at Serine 550. Mol Cell Biol (2016) 0.81
Role of leucocytes in free radical production during myocardial revascularisation. Heart (1997) 0.80
Morin, a flavonoid, on lipid peroxidation and antioxidant status in experimental myocardial ischemic rats. Afr J Tradit Complement Altern Med (2014) 0.80
Evaluation of a dithiocarbamate derivative as a model of thiol oxidative stress in H9c2 rat cardiomyocytes. Free Radic Biol Med (2014) 0.78
The Role of Oxidative Stress in Myocardial Ischemia and Reperfusion Injury and Remodeling: Revisited. Oxid Med Cell Longev (2016) 0.78
Pathobiology and Clinical Impact of Reperfusion Injury. J Thromb Thrombolysis (1995) 0.78
The occurrence of oxidative stress during reperfusion in experimental animals and men. Cardiovasc Drugs Ther (1991) 0.77
Protective effects of calcium antagonists against ischaemia and reperfusion damage. Drugs (1991) 0.77
Radiofrequency Renal Denervation Protects the Ischemic Heart via Inhibition of GRK2 and Increased Nitric Oxide Signaling. Circ Res (2016) 0.76
Commentary on myocardial stunning and its clinical relevance. Basic Res Cardiol (1996) 0.75
Luteolinidin protects the post-ischemic heart through CD38 inhibition with preservation of NAD(P)(H). J Pharmacol Exp Ther (2017) 0.75
Mechanisms of oxidative stress and myocardial protection during open-heart surgery. Ann Card Anaesth (2015) 0.75
The influence of Nrf2 on cardiac responses to environmental stressors. Oxid Med Cell Longev (2013) 0.75
Tolerance of myocardium of aged animals to repeated oxygen deficiency. Basic Res Cardiol (1992) 0.75
Defining the links between oxidative stress-based biomarkers and postoperative atrial fibrillation. J Am Heart Assoc (2015) 0.75
Isoflurane reduces oxygen-glucose deprivation-induced oxidative, inflammatory, and apoptotic responses in H9c2 cardiomyocytes. Am J Transl Res (2016) 0.75
Strophanthus hispidus attenuates the Ischemia-Reperfusion induced myocardial Infarction and reduces mean arterial pressure in renal artery occlusion. Pharmacogn Mag (2014) 0.75
Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation (1995) 2.91
Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation (2001) 2.85
Evaluation of phospholipid peroxidation as malondialdehyde during myocardial ischemia and reperfusion injury. Am J Physiol (1991) 2.28
Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-alpha. Eur Heart J (1999) 2.12
Exercise hyperventilation chronic congestive heart failure, and its relation to functional capacity and hemodynamics. Am J Cardiol (1992) 1.78
A simple way to treat chronic atrial fibrillation during mitral valve surgery: the epicardial radiofrequency approach. Eur J Cardiothorac Surg (2000) 1.72
Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes. Heart (2000) 1.58
Efficacy of ivabradine in combination with Beta-blocker versus uptitration of Beta-blocker in patients with stable angina. Cardiovasc Drugs Ther (2011) 1.56
Sensitivity, specificity, and predictive accuracies of non-invasive tests, singly and in combination, for diagnosis of hibernating myocardium. Eur Heart J (2000) 1.54
Non-invasive ventilation after cardiac surgery outside the Intensive Care Unit. Minerva Anestesiol (2010) 1.52
Mean cardiac output by thermodilution with a single controlled injection. Crit Care Med (2001) 1.46
PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol (1992) 1.43
Acute and short-term effects of partial left ventriculectomy in dilated cardiomyopathy: assessment by pressure-volume loops. J Am Coll Cardiol (2000) 1.40
Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation (2001) 1.40
Long-term results of coronary artery bypass grafting procedure in the presence of left ventricular dysfunction and hibernating myocardium. Eur J Cardiothorac Surg (2001) 1.37
The edge-to-edge technique: a simplified method to correct mitral insufficiency. Eur J Cardiothorac Surg (1998) 1.35
Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review. Ann N Y Acad Sci (2004) 1.32
The protective role of heat stress in the ischaemic and reperfused rabbit myocardium. J Mol Cell Cardiol (1992) 1.31
Mortality reduction in cardiac anesthesia and intensive care: results of the first International Consensus Conference. Acta Anaesthesiol Scand (2011) 1.31
Parapharyngeal space lesions syncope-syndrome. A newly proposed reflexogenic cardiovascular syndrome. Eur Heart J (1993) 1.30
Oxidative stress during myocardial ischaemia and heart failure. Curr Pharm Des (2004) 1.28
Echocardiography during infusion of dobutamine for identification of reversibly dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol (1994) 1.21
Oxygen-mediated myocardial damage during ischaemia and reperfusion: role of the cellular defences against oxygen toxicity. J Mol Cell Cardiol (1985) 1.20
Optimal exposure of the mitral valve through an extended vertical transeptal approach. Eur J Cardiothorac Surg (1991) 1.18
The double-orifice technique as a standardized approach to treat mitral regurgitation due to severe myxomatous disease: surgical technique. Eur J Cardiothorac Surg (2000) 1.18
Totally endoscopic computer-enhanced atrial septal defect closure in six patients. Ann Thorac Surg (2001) 1.15
Hemostatic effects of aprotinin, tranexamic acid and epsilon-aminocaproic acid in primary cardiac surgery. Ann Thorac Surg (1999) 1.12
The effects of ruthenium red on mitochondrial function during post-ischaemic reperfusion. J Mol Cell Cardiol (1982) 1.11
Mortality reduction in cardiac anesthesia and intensive care: results of the first International Consensus Conference. HSR Proc Intensive Care Cardiovasc Anesth (2011) 1.11
Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: role of tumor necrosis factor-alpha. Circulation (1999) 1.10
Left ventricular hypertrophy: a cytometric study on 42 human hearts. J Mol Cell Cardiol (1977) 1.10
Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition. Circulation (1998) 1.08
Oxidative stress during myocardial ischaemia and heart failure. Eur Heart J (1998) 1.04
Oxygen free radicals and myocardial damage: protective role of thiol-containing agents. Am J Med (1991) 1.04
Effect of alpha-tocopherol on hypoxic-perfused and reoxygenated rabbit heart muscle. J Mol Cell Cardiol (1978) 1.03
Enhanced expression and activity of xanthine oxidoreductase in the failing heart. J Mol Cell Cardiol (2000) 1.02
The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of N-acetyl cysteine. J Mol Cell Cardiol (1988) 1.01
Improved results with mitral valve repair using new surgical techniques. Eur J Cardiothorac Surg (1995) 1.01
Valve repair for traumatic tricuspid regurgitation. Eur J Cardiothorac Surg (1996) 1.01
Changes in the cardiac glutathione status after ischemia and reperfusion. Experientia (1985) 1.00
Surgical treatment of tetralogy of Fallot with pulmonary atresia. J Thorac Cardiovasc Surg (1978) 1.00
Apoptosis of skeletal muscle myofibers and interstitial cells in experimental heart failure. J Mol Cell Cardiol (1998) 0.99
New insights on myocardial pyridine nucleotides and thiol redox state in ischemia and reperfusion damage. Cardiovasc Res (2000) 0.98
Risk stratification for open heart operations: comparison of centers regardless of the influence of the surgical team. Ann Thorac Surg (1997) 0.98
Metabolic adaptation during a sequence of no-flow and low-flow ischemia. A possible trigger for hibernation. Circulation (1996) 0.97
Pulsed tissue Doppler imaging detects early myocardial dysfunction in asymptomatic patients with severe mitral regurgitation. Heart (2004) 0.97
Neurohormones, cytokines and programmed cell death in heart failure: a new paradigm for the remodeling heart. Cardiovasc Drugs Ther (2001) 0.97
Effectiveness of intravenous rTPA in the treatment of massive pulmonary embolism and right heart thromboembolism. Am Heart J (1993) 0.97
Noninvasive evaluation of the effects of oral ibopamine (SB 7505) on cardiac and renal function in patients with congestive heart failure. J Cardiovasc Pharmacol (1982) 0.96
Effects of 17 beta-estradiol on the isolated rabbit heart. Arch Int Pharmacodyn Ther (1986) 0.96
Skeletal muscle myosin heavy chain expression in rats with monocrotaline-induced cardiac hypertrophy and failure. Relation to blood flow and degree of muscle atrophy. Cardiovasc Res (1998) 0.96
Activation of coagulation and fibrinolysis during coronary surgery: on-pump versus off-pump techniques. Anesthesiology (2001) 0.96
Myocardial recovery during post-ischaemic reperfusion: effects of nifedipine, calcium and magnesium. J Mol Cell Cardiol (1986) 0.96
Right ventricular hypertrophy--a cytometric study on 55 human hearts. J Mol Cell Cardiol (1971) 0.95
Assessment of myocardial perfusion with thallium-201 scintigraphy in exercise-induced left bundle branch block: diagnostic value and clinical significance. Eur Heart J (1992) 0.94
Hemodynamic effects of ibopamine in patients with idiopathic congestive cardiomyopathy. J Cardiovasc Pharmacol (1983) 0.94
The Senning operation for transposition of the great arteries. J Thorac Cardiovasc Surg (1978) 0.94
Ultrastructural basis of acute left ventricular failure from severe acute aortic stenosis in the rabbit. J Mol Cell Cardiol (1972) 0.93
Non-invasive evaluation of left ventricular function through systolic time intervals following oral administration of SB 7505 in man. Arzneimittelforschung (1980) 0.93
Different prognostic value of exercise electrocardiogram in men and women. Cardiology (1978) 0.92
Syncope and tumours in the neck: carotid sinus or glossopharyngeal syndrome? Eur Heart J (1985) 0.92
The hemodynamic effects of double-orifice valve repair for mitral regurgitation: a 3D computational model. Eur J Cardiothorac Surg (1999) 0.91
Metabolic derangement in ischemic heart disease and its therapeutic control. Am J Cardiol (1998) 0.91
Surgical management of left ventricular free wall rupture after acute myocardial infarction. Cardiovasc Surg (1995) 0.91
Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression. Br J Pharmacol (2012) 0.90
Endothelial function and dysfunction in heart failure. Eur Heart J (1998) 0.90
[Post-traumatic pseudoaneurysm of the mitral-aortic intervalvular fibrosa]. G Ital Cardiol (1990) 0.90
Myocardial blood flow in experimental cardiac hypertrophy in dogs. Cardiovasc Res (1973) 0.89
Iopamidol: a new contrast medium in coronary angiography. Comparison, on electrophysiological changes in man, with a commonly used contrast medium. Eur Heart J (1983) 0.89
Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions. J Thorac Cardiovasc Surg (2000) 0.89